154 related articles for article (PubMed ID: 34879274)
1. Genome-wide fitness gene identification reveals Roquin as a potent suppressor of CD8 T cell expansion and anti-tumor immunity.
Zhao H; Liu Y; Wang L; Jin G; Zhao X; Xu J; Zhang G; Ma Y; Yin N; Peng M
Cell Rep; 2021 Dec; 37(10):110083. PubMed ID: 34879274
[TBL] [Abstract][Full Text] [Related]
2. Potent immunotherapy against well-established thymoma using adoptively transferred transgene IL-6-engineered dendritic cell-stimulated CD8+ T-cells with prolonged survival and enhanced cytotoxicity.
Kalyanasundaram Bhanumathy K; Zhang B; Xie Y; Xu A; Tan X; Xiang J
J Gene Med; 2015; 17(8-9):153-60. PubMed ID: 26212685
[TBL] [Abstract][Full Text] [Related]
3. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
Lutz-Nicoladoni C; Wallner S; Stoitzner P; Pircher M; Gruber T; Wolf AM; Gastl G; Penninger JM; Baier G; Wolf D
Immunol Cell Biol; 2012 Jan; 90(1):130-4. PubMed ID: 21383769
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of lymphotactin and interferon gamma-inducible protein-10 transgene expression in T-cell localization and adoptive T-cell therapy of tumors.
Huang H; Xiang J
Int J Cancer; 2004 May; 109(6):817-25. PubMed ID: 15027114
[TBL] [Abstract][Full Text] [Related]
5. Disrupting Roquin-1 interaction with Regnase-1 induces autoimmunity and enhances antitumor responses.
Behrens G; Edelmann SL; Raj T; Kronbeck N; Monecke T; Davydova E; Wong EH; Kifinger L; Giesert F; Kirmaier ME; Hohn C; de Jonge LS; Pisfil MG; Fu M; Theurich S; Feske S; Kawakami N; Wurst W; Niessing D; Heissmeyer V
Nat Immunol; 2021 Dec; 22(12):1563-1576. PubMed ID: 34811541
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific clonal expansion and cytolytic effector function of CD8+ T lymphocytes depend on the transcription factor Bcl11b.
Zhang S; Rozell M; Verma RK; Albu DI; Califano D; VanValkenburgh J; Merchant A; Rangel-Moreno J; Randall TD; Jenkins NA; Copeland NG; Liu P; Avram D
J Exp Med; 2010 Aug; 207(8):1687-99. PubMed ID: 20660613
[TBL] [Abstract][Full Text] [Related]
7. A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells.
Oba T; Hoki T; Yamauchi T; Keler T; Marsh HC; Cao X; Ito F
J Immunol; 2020 Oct; 205(7):1867-1877. PubMed ID: 32848036
[TBL] [Abstract][Full Text] [Related]
8. Interferon regulatory factor 4 deficiency in CD8
Zou D; Fu J; Guo Z; Chen W
Immunology; 2020 Dec; 161(4):364-379. PubMed ID: 32892353
[TBL] [Abstract][Full Text] [Related]
9. Breakdown in repression of IFN-γ mRNA leads to accumulation of self-reactive effector CD8+ T cells.
Chang PP; Lee SK; Hu X; Davey G; Duan G; Cho JH; Karupiah G; Sprent J; Heath WR; Bertram EM; Vinuesa CG
J Immunol; 2012 Jul; 189(2):701-10. PubMed ID: 22685317
[TBL] [Abstract][Full Text] [Related]
10. Interferon regulatory factor 4 controls effector functions of CD8
Harberts A; Schmidt C; Schmid J; Reimers D; Koch-Nolte F; Mittrücker HW; Raczkowski F
Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33859042
[TBL] [Abstract][Full Text] [Related]
11. Differential requirements for IRF4 in the clonal expansion and homeostatic proliferation of naive and memory murine CD8
Miyakoda M; Honma K; Kimura D; Akbari M; Kimura K; Matsuyama T; Yui K
Eur J Immunol; 2018 Aug; 48(8):1319-1328. PubMed ID: 29745988
[TBL] [Abstract][Full Text] [Related]
12. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice.
Hsu FT; Chen TC; Chuang HY; Chang YF; Hwang JJ
Oncotarget; 2015 Dec; 6(42):44134-50. PubMed ID: 26683520
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity.
Zhou J; Kryczek I; Li S; Li X; Aguilar A; Wei S; Grove S; Vatan L; Yu J; Yan Y; Liao P; Lin H; Li J; Li G; Du W; Wang W; Lang X; Wang W; Wang S; Zou W
Nat Immunol; 2021 Apr; 22(4):460-470. PubMed ID: 33767425
[TBL] [Abstract][Full Text] [Related]
16. Loss of Roquin induces early death and immune deregulation but not autoimmunity.
Bertossi A; Aichinger M; Sansonetti P; Lech M; Neff F; Pal M; Wunderlich FT; Anders HJ; Klein L; Schmidt-Supprian M
J Exp Med; 2011 Aug; 208(9):1749-56. PubMed ID: 21844204
[TBL] [Abstract][Full Text] [Related]
17. Development of a CD8 co-receptor independent T-cell receptor specific for tumor-associated antigen MAGE-A4 for next generation T-cell-based immunotherapy.
Davari K; Holland T; Prassmayer L; Longinotti G; Ganley KP; Pechilis LJ; Diaconu I; Nambiar PR; Magee MS; Schendel DJ; Sommermeyer D; Ellinger C
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33771892
[TBL] [Abstract][Full Text] [Related]
18. Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy.
Chacon JA; Wu RC; Sukhumalchandra P; Molldrem JJ; Sarnaik A; Pilon-Thomas S; Weber J; Hwu P; Radvanyi L
PLoS One; 2013; 8(4):e60031. PubMed ID: 23560068
[TBL] [Abstract][Full Text] [Related]
19. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J
Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618
[TBL] [Abstract][Full Text] [Related]
20. Targeting STAT3 in adoptively transferred T cells promotes their in vivo expansion and antitumor effects.
Kujawski M; Zhang C; Herrmann A; Reckamp K; Scuto A; Jensen M; Deng J; Forman S; Figlin R; Yu H
Cancer Res; 2010 Dec; 70(23):9599-610. PubMed ID: 21118964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
